Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer

Platinum chemotherapy remains the cornerstone of treatment for epithelial ovarian cancer (OC) and Poly (ADP-ribose) polymerase inhibitors (PARPi) now have an established role as maintenance therapy. The mechanisms of action of these agents is, in many ways, complementary, and crucially reliant on th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Michelle McMullen, Katherine Karakasis, Ainhoa Madariaga, Amit M. Oza
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-06-01
Serija:Cancers
Teme:
resistance mechanisms
platinum
PARP
ovarian cancer
homologous recombination
Online dostop:https://www.mdpi.com/2072-6694/12/6/1607
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki